1552 related articles for article (PubMed ID: 34169443)
21. A Review of Neurological Involvement in Patients with SARS-CoV-2 Infection.
Xu Y; Zhuang Y; Kang L
Med Sci Monit; 2021 Jun; 27():e932962. PubMed ID: 34145211
[TBL] [Abstract][Full Text] [Related]
22. Molecular Mechanisms of SARS-CoV-2/COVID-19 Pathogenicity on the Central Nervous System: Bridging Experimental Probes to Clinical Evidence and Therapeutic Interventions.
Groppa SA; Ciolac D; Duarte C; Garcia C; Gasnaș D; Leahu P; Efremova D; Gasnaș A; Bălănuță T; Mîrzac D; Movila A
Adv Exp Med Biol; 2022; 1376():1-27. PubMed ID: 34735712
[TBL] [Abstract][Full Text] [Related]
23. Impact of SARS-CoV-2 on the nervous system.
Czarnowska A; Zajkowska J; Kułakowska A
Neurol Neurochir Pol; 2023; 57(1):26-35. PubMed ID: 36799524
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 and neurologic manifestations: a synthesis from the child neurologist's corner.
Valderas C; Méndez G; Echeverría A; Suarez N; Julio K; Sandoval F
World J Pediatr; 2022 Jun; 18(6):373-382. PubMed ID: 35476245
[TBL] [Abstract][Full Text] [Related]
25. A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development.
Karnik M; Beeraka NM; Uthaiah CA; Nataraj SM; Bettadapura ADS; Aliev G; Madhunapantula SV
Mol Neurobiol; 2021 Sep; 58(9):4535-4563. PubMed ID: 34089508
[TBL] [Abstract][Full Text] [Related]
26. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment.
Zhang Y; Chen X; Jia L; Zhang Y
Acta Neurol Scand; 2022 Sep; 146(3):225-236. PubMed ID: 35699161
[TBL] [Abstract][Full Text] [Related]
27. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
[TBL] [Abstract][Full Text] [Related]
28. Neurological Complications of COVID-19: Underlying Mechanisms and Management.
Shehata GA; Lord KC; Grudzinski MC; Elsayed M; Abdelnaby R; Elshabrawy HA
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920904
[TBL] [Abstract][Full Text] [Related]
29. Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19.
Stefano GB; Büttiker P; Weissenberger S; Ptacek R; Wang F; Esch T; Bilfinger TV; Raboch J; Kream RM
Curr Neuropharmacol; 2022; 20(6):1229-1240. PubMed ID: 34951387
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.
Amadoro G; Latina V; Stigliano E; Micera A
Cells; 2023 Nov; 12(22):. PubMed ID: 37998336
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?
Ferini-Strambi L; Salsone M
J Neurol; 2021 Feb; 268(2):409-419. PubMed ID: 32696341
[TBL] [Abstract][Full Text] [Related]
32. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System.
De Felice FG; Tovar-Moll F; Moll J; Munoz DP; Ferreira ST
Trends Neurosci; 2020 Jun; 43(6):355-357. PubMed ID: 32359765
[TBL] [Abstract][Full Text] [Related]
33. Neurological manifestations and pathogenic mechanisms of COVID-19.
Galea M; Agius M; Vassallo N
Neurol Res; 2022 Jul; 44(7):571-582. PubMed ID: 34986754
[TBL] [Abstract][Full Text] [Related]
34. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
Harapan BN; Yoo HJ
J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
[TBL] [Abstract][Full Text] [Related]
35. The Impact of COVID-19 on People Living with HIV-1 and HIV-1-Associated Neurological Complications.
Dutta D; Liu J; Xiong H
Viruses; 2023 May; 15(5):. PubMed ID: 37243203
[TBL] [Abstract][Full Text] [Related]
36. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
Achar A; Ghosh C
Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
[TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.
Tsatsakis A; Calina D; Falzone L; Petrakis D; Mitrut R; Siokas V; Pennisi M; Lanza G; Libra M; Doukas SG; Doukas PG; Kavali L; Bukhari A; Gadiparthi C; Vageli DP; Kofteridis DP; Spandidos DA; Paoliello MMB; Aschner M; Docea AO
Food Chem Toxicol; 2020 Dec; 146():111769. PubMed ID: 32979398
[TBL] [Abstract][Full Text] [Related]
38. Neurological Manifestations of Acute SARS-CoV-2 Infection in Pediatric Patients: A 3-Year Study on Differences between Pandemic Waves.
Vivisenco IC; Lescaie A; Dragomirescu A; Ioniță IC; Florescu I; Ciocea B; Grama AR; Crăciun MD; Chivu CD; Ulmeanu CE; Nițescu VG
Viruses; 2024 Jun; 16(6):. PubMed ID: 38932259
[TBL] [Abstract][Full Text] [Related]
39. Emerging neurotropic features of SARS-CoV-2.
Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
[TBL] [Abstract][Full Text] [Related]
40. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain.
Li Z; Liu T; Yang N; Han D; Mi X; Li Y; Liu K; Vuylsteke A; Xiang H; Guo X
Front Med; 2020 Oct; 14(5):533-541. PubMed ID: 32367431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
